Epilepsy trials recruiting in Arizona

All Epilepsy trials nationally

Cities in Arizona

Recruiting trials in Arizona

• A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
  NCT06872125 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Arizona: Phoenix
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
  NCT06132893 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Arizona: Phoenix, Tucson
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
  NCT05667142 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Arizona: Phoenix, Tucson
• AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
  NCT06063850 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Arizona: Phoenix
• An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
  NCT06908356 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Arizona: Phoenix
• Diagnosing Epilepsy To EffeCT Change
  NCT07110337 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Arizona: Phoenix
• Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
  NCT07110454 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · Arizona: Phoenix
• Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
  NCT07051629 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Arizona: Tucson
• Epilepsy Learning Healthcare System (ELHS)
  NCT06265103 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Arizona: Phoenix
• Epilepsy Seizure Detection With Innovative Tripolar EEG (tEEG)
  NCT05944692 · Phase: Not specified · Ages: 6 Years and older · Sex: All (male and female) · Arizona: Phoenix
• Patterns of Neurodevelopmental Disorders
  NCT06213090 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Arizona: Phoenix
• Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
  NCT05135091 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Arizona: Phoenix, Tucson
• Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
  NCT04322734 · Phase: Not specified · Ages: Up to 18 Years · Sex: All (male and female) · Arizona: Phoenix